Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling
Jiajing Zhao(Shenzhen Second People's Hospital), Jianwei Huang(Central Hospital of Putuo District)
Cited by 19
Related Papers
No related papers found
Powered by citation graph analysis